Using a Biologic in a Patient with Atopic Dermatitis and HSV Keratitis

Published: Feb. 28, 2020, 5 a.m.

Guest: Peter A. Lio, MD
\n\n Guest: Mark Boguniewicz, MD
\n\n Guest: Eric Simpson, MD, MCR
\n\n\n \n

Please note: This activity is no longer available for continuing education credit.

A multidisiplinary panel is presented with a highly allergic, extremely refractory patient with atopic dermatitis. Her dermatologist wants to take the next step and start her on a biologic, but she's worried about the patient's occular history and dupilumab's conjunctivitis risk. Find out what the experts have to say about this doctor's dilemma.